HEB - Hemispherx Biopharma, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts2222
Avg. Estimate-1.41-1.24-5.97-3.69
Low Estimate-1.44-1.42-6.18-4.99
High Estimate-1.38-1.06-5.76-2.39
Year Ago EPS-3.08-1.32-9.68-5.97
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts2222
Avg. Estimate70k200k330k420k
Low Estimate70k90k240k240k
High Estimate80k300k430k600k
Year Ago SalesN/A240k367k330k
Sales Growth (year/est)N/A-16.70%-10.10%27.30%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-2.64-3.08-2.2-1.7
EPS Actual-3.08-1.32-3.08-1.07
Difference-0.441.76-0.880.63
Surprise %-16.70%57.10%-40.00%37.10%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-1.41-1.24-5.97-3.69
7 Days Ago-1.41-1.24-5.97-3.69
30 Days Ago-1.71-1.46-7.14-4.46
60 Days Ago-1.71-1.46-7.14-4.46
90 Days Ago-0.04-0.04-0.17-0.15
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days2221
Up Last 30 Days2221
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/A1
Growth EstimatesHEBIndustrySectorS&P 500
Current Qtr.54.20%N/AN/A-0.02
Next Qtr.6.10%N/AN/A0.07
Current Year38.30%N/AN/A-0.02
Next Year38.20%N/AN/A0.14
Next 5 Years (per annum)25.00%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A